Diligence memo · auto-generated · as of July 2, 2026
Pegasus Development, Inc.
Pegasus Development, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Pegasus Development, Inc. operates in Other Health Care, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pegasus Development, Inc. has raised $30M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $30M on 2020-12-14.
Most recent recorded round closed around 2020-12-14.
Valuation (modeled)modeled
Provath models Pegasus Development, Inc. at approximately $579M (range $71M–$2.0B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.55× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.
Financing rhythm & timingmixed
Last raise 5.5 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 88% of Other Health Care peers (5377 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: KSMS Holdings, LLC, Infab HoldCo, Inc., Aquity Holdings, Inc., MHH Management Holdco, LLC, Earli Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.